Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C3H3N3O2S |
| Molecular Weight | 145.14 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC=C(S1)[N+]([O-])=O
InChI
InChIKey=MIHADVKEHAFNPG-UHFFFAOYSA-N
InChI=1S/C3H3N3O2S/c4-3-5-1-2(9-3)6(7)8/h1H,(H2,4,5)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| N-(4-Meth-oxy-phen-yl)-N'-(5-nitro-1,3-thia-zol-2-yl)urea. | 2010-08-18 |
|
| Biological activity of modified and exchanged 2-amino-5-nitrothiazole amide analogues of nitazoxanide. | 2010-06-15 |
|
| Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies. | 2005-12-01 |
|
| Cryptobia iubilans infection in juvenile discus. | 2004-05-15 |
|
| 2-Amino-5-nitrothiazole monoethanol solvate: triply-interwoven hydrogen-bonded sheets containing centrosymmetric R2 2(8) and RR10 10(38) rings. | 2004-01 |
|
| Bioassay of 2-amino-5-nitrothiazole for possible carcinogenicity. | 1978 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QP51AX16
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
||
|
NCI_THESAURUS |
C277
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C76409
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | |||
|
8486
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | |||
|
m1723
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | Merck Index | ||
|
300000033070
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | |||
|
C034870
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | |||
|
1665683
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | RxNorm | ||
|
121-66-4
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | |||
|
4
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | |||
|
1463971
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | |||
|
1GR77A37Z5
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | |||
|
204-490-9
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | |||
|
DTXSID6020066
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | |||
|
1GR77A37Z5
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY | |||
|
4022
Created by
admin on Mon Mar 31 21:23:39 GMT 2025 , Edited by admin on Mon Mar 31 21:23:39 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
